Arena Pharmaceuticals, (ARNA) Posts Wider than Expected Q4 Loss of 16c/Share

March 14, 2012 4:11 PM EDT Send to a Friend
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q4 EPS of ($0.16), $0.01 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $2.08 million versus the consensus estimate of $3.49 million.

For earnings history and earnings-related data on Arena Pharmaceuticals, Inc. (ARNA) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment